Radiation Oncology/Therapy: Page 262

Mayo plans to build proton therapy centers
By AuntMinnie.com staff writers
The Mayo Clinic in Rochester, MN, has announced plans to establish a proton-beam therapy program at its three cancer centers in Arizona, Florida, and Minnesota.
November 16, 2010
IsoRay Q1 sales dip by 4%
By AuntMinnie.com staff writers
Product sales decreased slightly for medical isotope developer IsoRay Medical in the company's first quarter of its 2011 fiscal year.
November 15, 2010
FDG-PET/CT aids evaluation of bladder cancer patients
By Wayne Forrest
Wednesday, December 1 | 3:30 p.m.-3:40 p.m. | SSM18-04 | Room S505ABFDG-PET/CT is helpful in accurately assessing disease and can provide significant prognostic information in patients with urothelial cancer. So concluded researchers from Johns Hopkins University in Baltimore in their study scheduled to be presented Wednesday afternoon at RSNA 2010.
November 15, 2010
F-18 NaF boosts sensitivity to detect malignancies with FDG-PET/CT
By Wayne Forrest
Wednesday, December 1 | 11:20 a.m.-11:30 a.m. | SSK13-06 | Room S505ABOn Wednesday morning, researchers from Stanford University in Stanford, CA, will show preliminary study results that "strongly suggest" dual-tracer PET/CT imaging with FDG and F-18 sodium fluoride (F-18 NaF) increases the sensitivity of detecting malignancy compared to FDG alone.
November 15, 2010
FDG-PET can help with early tumor detection in Li-Fraumeni syndrome
By Wayne Forrest
Wednesday, December 1 | 11:00 a.m.-11:10 a.m. | SSK13-04 | Room S505ABResearchers in Brazil have found that PET/CT can be a useful clinical tool for detecting unknown and early-stage cancer sites in high-risk asymptomatic patients with Li-Fraumeni syndrome.
November 15, 2010
PET/CT tops CT alone for head and neck squamous cell carcinoma
By Wayne Forrest
Tuesday, November 30 | 10:30 a.m.-10:40 a.m. | SSG12-01 | Room S505ABPET/CT is superior to high-resolution CT alone, particularly regarding sensitivity, in cases of head and neck squamous cell carcinoma, according to a study by researchers from Mount Sinai School of Medicine in New York City.
November 15, 2010
CAD shows promise for evaluating prostate cancer aggressiveness
By Erik L. Ridley
Sunday, November 28 | 11:55 a.m.-12:05 p.m. | SSA10-08 | Room E353BResearchers from the University of Chicago will describe the potential for their prototype computer-aided detection (CAD) software in prostate MRI in this Sunday scientific session.
November 14, 2010
Contrast ultrasound characterizes incidental liver lesions found on CT and MRI
By Brian Casey
Monday, November 29 | 9:05 a.m.-9:15 a.m. | VG21-03 | Room E353AUltrasound scans with a microbubble-based contrast agent can be used to characterize solid focal liver lesions detected as incidental findings on CT and MRI scans, potentially enabling patients to avoid liver biopsies, according to a study from Italy.
November 11, 2010
Contrast ultrasound assesses treatment response in liver cancer
By Brian Casey
Monday, November 29 | 8:55 a.m.-9:05 a.m. | VG21-02 | Room E353AIn this Monday morning presentation, researchers will present a technique using dynamic contrast-enhanced ultrasound to assess the response to chemotherapy in patients with liver cancer.
November 11, 2010
Low-frequency ultrasound releases cancer biomarkers
By Brian Casey
Sunday, November 28 | 10:45 a.m.-10:55 a.m. | SSA21-01 | Room S504ABIn this Sunday morning presentation, researchers from Stanford University in Stanford, CA, will demonstrate their use of low-frequency ultrasound to sonicate cells and release blood biomarkers that could improve detection of occult cancers.
November 11, 2010
Accuray revenues slump in Q1
By AuntMinnie.com staff writers
Radiation therapy firm Accuray reported a 22% decrease in revenues, which it attributed to a seasonality of its business in the first quarter of fiscal 2010.
November 8, 2010
Toxicity risk high for patients in phase I clinical trials
By Cynthia E. Keen
What is the risk to patients who enroll in phase I radiation oncology clinical trials? With respect to toxicities, it may be considerable, according to a study presented at the recent American Society for Radiation Oncology annual meeting.
November 8, 2010
Previous Page
Page 262 of 468
Next Page